buspirone has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 4 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Buspirone is a serotonin 5-HT(1A) receptor agonist licensed for the treatment of anxiety." | 2.73 | Lack of deleterious effects of buspirone on cognition in healthy male volunteers. ( Aitken, MR; Cardinal, RN; Chamberlain, SR; Corlett, PR; Deakin, JB; Dowson, J; Müller, U; Robbins, TW; Sahakian, BJ, 2007) |
| "Kleptomania is currently classified in psychiatric nomenclature as one of the impulse control disorders (DSM-IV, 1994)." | 1.30 | [Kleptomania: phenomenological, clinical and legal aspects]. ( Durst, R; Jabotinsky-Rubin, K; Katz, G; Knobler, HY, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chamberlain, SR | 1 |
| Müller, U | 1 |
| Deakin, JB | 1 |
| Corlett, PR | 1 |
| Dowson, J | 1 |
| Cardinal, RN | 1 |
| Aitken, MR | 1 |
| Robbins, TW | 1 |
| Sahakian, BJ | 1 |
| Waller, DA | 1 |
| Sheinberg, Al | 1 |
| Gullion, C | 1 |
| Moeller, FG | 1 |
| Cannon, DS | 1 |
| Petty, F | 1 |
| Hardy, BW | 1 |
| Orsulak, P | 1 |
| Rush, AJ | 1 |
| Durst, R | 2 |
| Katz, G | 2 |
| Knobler, HY | 2 |
| Jabotinsky-Rubin, K | 1 |
2 trials available for buspirone and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Lack of deleterious effects of buspirone on cognition in healthy male volunteers.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Anxiety Agents; Buspirone; Cognition; Decision Making; | 2007 |
Impulsivity and neuroendocrine response to buspirone in bulimia nervosa.
Topics: Adrenocorticotropic Hormone; Adult; Bulimia; Buspirone; Disruptive, Impulse Control, and Conduct Dis | 1996 |
2 other studies available for buspirone and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Buspirone augmentation of fluvoxamine in the treatment of kleptomania.
Topics: Adult; Buspirone; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; | 1997 |
[Kleptomania: phenomenological, clinical and legal aspects].
Topics: Adult; Buspirone; Disruptive, Impulse Control, and Conduct Disorders; Fluvoxamine; Humans; Male; Obs | 1997 |